122 related articles for article (PubMed ID: 10382641)
1. Paediatric liver transplantation: indications, timing and medical complications.
Cox KL; Berquist WE; Castillo RO
J Gastroenterol Hepatol; 1999 May; 14 Suppl():S61-6. PubMed ID: 10382641
[TBL] [Abstract][Full Text] [Related]
2. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Newell KA; Alonso EM; Kelly SM; Rubin CM; Thistlethwaite JR; Whitington PF
J Pediatr; 1997 Jul; 131(1 Pt 1):98-104. PubMed ID: 9255199
[TBL] [Abstract][Full Text] [Related]
3. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation in infants younger than 1 year of age.
Colombani PM; Cigarroa FG; Schwarz K; Wise B; Maley WE; Klein AS
Ann Surg; 1996 Jun; 223(6):658-62; discussion 662-4. PubMed ID: 8645039
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Newell KA; Alonso EM; Whitington PF; Bruce DS; Millis JM; Piper JB; Woodle ES; Kelly SM; Koeppen H; Hart J; Rubin CM; Thistlethwaite JR
Transplantation; 1996 Aug; 62(3):370-5. PubMed ID: 8779685
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
[TBL] [Abstract][Full Text] [Related]
7. Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine.
Zajicek A; Esquivel C; Millan M; Cox K; Berquist R; Berquist W
Transplant Proc; 2002 Aug; 34(5):1976-8. PubMed ID: 12176653
[No Abstract] [Full Text] [Related]
8. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.
Wiederkehr JC; Coelho IM; Avilla SG; e Silva EM; Schuller S; Ouno DD; Wiederkehr BA; Polimeni M
Transplant Proc; 2010 Mar; 42(2):521-2. PubMed ID: 20304183
[TBL] [Abstract][Full Text] [Related]
9. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
[TBL] [Abstract][Full Text] [Related]
10. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.
Cox KL; Lawrence-Miyasaki LS; Garcia-Kennedy R; Lennette ET; Martinez OM; Krams SM; Berquist WE; So SK; Esquivel CO
Transplantation; 1995 Feb; 59(4):524-9. PubMed ID: 7533344
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern.
Malatack JF; Gartner JC; Urbach AH; Zitelli BJ
J Pediatr; 1991 May; 118(5):667-75. PubMed ID: 1850458
[TBL] [Abstract][Full Text] [Related]
12. [Management of pediatric patients who underwent liver transplantation].
Wang ZL; Wang XH; Zheng S
Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):428-31. PubMed ID: 17880788
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after liver transplantation.
Ryckman FC; Alonso MH; Bucuvalas JC; Balistreri WF
J Pediatr Surg; 1999 May; 34(5):845-9; discussion 849-50. PubMed ID: 10359193
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan ML; Scantlebury VP; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala TR; Simmons RL; Fung JJ; Starzl TE
Transplantation; 1999 Dec; 68(12):1851-4. PubMed ID: 10628763
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative intensive care of biliary atresia patients treated with living donor liver transplantation].
Deng YH; Guo CB; Zhang MM; Li YC
Zhonghua Er Ke Za Zhi; 2011 Jan; 49(1):21-6. PubMed ID: 21429307
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation at Red Cross War Memorial Children's Hospital.
Spearman CW; McCulloch M; Millar AJ; Burger H; Numanoglu A; Goddard E; Gajjar P; Davies C; Muller E; McCurdie F; Kemm D; Cywes S; Rode H; Khan D
S Afr Med J; 2006 Sep; 96(9 Pt 2):960-3. PubMed ID: 17077925
[TBL] [Abstract][Full Text] [Related]
18. Complications in paediatric liver transplant from Kuwait when transplanted abroad.
Al-Khalidi JA; Alenezi B; Al-Qabandy W; Abo-Hamra E; Husain K; Askar HA; Jagannathan AP; Abu-El-Naga H; Neff GW
Arab J Gastroenterol; 2012 Dec; 13(4):178-9. PubMed ID: 23432986
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation.
Granot E; Doron D; Morag R
Transplant Proc; 2000 Jun; 32(4):706-7. PubMed ID: 10856551
[No Abstract] [Full Text] [Related]
20. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
